BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 24, 2026
Home » Newsletters » BioWorld

BioWorld

April 9, 2018

View Archived Issues

Money raised by biotech: Jan. 1 - April 5, 2018

Read More

Money raised by biotech: 2018 vs. 2017

Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More

Milestone payments from corporate partners in March 2018

Read More

BioWorld Stock Index 2018

Read More

Venture capital and other investments in private biotech companies in March 2018

Read More

Other financings of public biotechnology companies in March 2018

Read More

Public financing of biotechnology companies: Filed and pending IPOs in March 2018

Read More

Biopharmas source record amounts of venture capital

It looks like private companies can do no wrong as far as raising capital is concerned. Last year, global companies collectively raised $10.9 billion, a total that stands as a record for the industry. However, that amount could be quickly eclipsed based on the $4 billion generated in the first quarter of this year. The total represents almost double the amounts raised in the first quarters of 2017 ($2.15 billion) and 2015 ($2.29 billion), the two years that currently hold the number one and two positions for most private money raised annually by the industry at $10.9 billion and $10.35 billion, respectively. Read More

Week in review

Read More

Word on the street

Read More

Week in Washington

Read More

Uncertain financial markets not a barrier to follow-on deals

At one time the industry would congratulate itself if it managed to raise $20 billion in a single year. Now companies appear to have no difficulty capturing that amount over a three-month period whether the financial markets are favorable or not. Read More

Biotech money raised by month in 2018

Read More

Public financing of biotechnology companies: Commenced trading in March 2018

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing